|
AU2002218026A1
(en)
|
2000-11-09 |
2002-05-21 |
The Brigham And Women's Hospital, Inc. |
Cardiovascular disease diagnostic and therapeutic targets
|
|
US7713705B2
(en)
*
|
2002-12-24 |
2010-05-11 |
Biosite, Inc. |
Markers for differential diagnosis and methods of use thereof
|
|
US7524635B2
(en)
|
2003-04-17 |
2009-04-28 |
Biosite Incorporated |
Methods and compositions for measuring natriuretic peptides and uses thereof
|
|
AUPS169202A0
(en)
*
|
2002-04-11 |
2002-05-16 |
Goetze, Jens Peter |
Neuropeptide assay
|
|
ES2375181T3
(en)
|
2002-05-09 |
2012-02-27 |
The Brigham And Women's Hospital, Inc. |
1L 1RL-1 AS A MARKER OF CARDIOVASCULAR DISEASES.
|
|
FR2843396B1
(en)
*
|
2002-08-07 |
2005-04-15 |
Bio Rad Pasteur |
SPECIFIC ANTIBODIES FOR THE DIAGNOSIS OF HEART FAILURE
|
|
GB0224425D0
(en)
*
|
2002-10-21 |
2002-11-27 |
Univ Leicester |
Method for prediction of cardiac disease
|
|
US6960472B2
(en)
*
|
2002-11-18 |
2005-11-01 |
Ottawa Heart Institute Research Corporation |
Monoclonal antibodies against N-Terminus proBNP
|
|
US20050287613A1
(en)
*
|
2002-11-18 |
2005-12-29 |
George Jackowski |
Polyclonal-polyclonal ELISA assay for detecting N-terminus-proBNP
|
|
EP1562990B1
(en)
*
|
2002-11-18 |
2010-07-21 |
Syn X Pharma, Inc. |
Polyclonal-monoclonal elisa assay for detecting n-terminus probnp
|
|
US20040096919A1
(en)
*
|
2002-11-18 |
2004-05-20 |
Michelle Davey |
Polyclonal-monoclonal ELISA assay for detecting N-terminus proBNP
|
|
WO2004099252A1
(en)
|
2003-05-12 |
2004-11-18 |
Roche Diagnostics Gmbh |
Method of detecting native probnp with amonoclonal antibody binding to the amino acids 38-44
|
|
GB2403533A
(en)
|
2003-06-30 |
2005-01-05 |
Orion Corp |
Atrial natriuretic peptide and brain natriuretic peptide and assays and uses thereof
|
|
DE10355731A1
(en)
*
|
2003-11-28 |
2005-06-30 |
Roche Diagnostics Gmbh |
Analytical sandwich test to determine NT-proBNP
|
|
AT500800B1
(en)
*
|
2004-09-08 |
2008-07-15 |
Biomedica Medizinprodukte Gmbh |
PROCESS FOR DETERMINING PROBNP
|
|
FR2863269B1
(en)
*
|
2005-01-14 |
2006-05-26 |
Bio Rad Pasteur |
SPECIFIC PEPTIDES FOR THE DIAGNOSIS OF HEART FAILURE
|
|
DK2386860T3
(en)
|
2006-04-24 |
2015-02-09 |
Critical Care Diagnostics Inc |
Prediction of mortality and detection of severe illness
|
|
WO2007130962A2
(en)
|
2006-05-01 |
2007-11-15 |
Critical Care Diagnostics, Inc. |
Diagnosis of cardiovascular disease
|
|
US8147817B2
(en)
|
2006-05-04 |
2012-04-03 |
The Brigham And Women's Hospital, Inc. |
IL-33 in the treatment and diagnosis of diseases and disorders
|
|
ES2430290T3
(en)
*
|
2007-03-06 |
2013-11-19 |
F. Hoffmann-La Roche Ag |
Use of PNC type peptides to predict the need for dialysis
|
|
AT504942B1
(en)
|
2007-03-07 |
2009-08-15 |
Biomedica Medizinprodukte Gmbh |
PROCESS FOR DETERMINING PROBNP
|
|
US9482677B2
(en)
|
2008-02-27 |
2016-11-01 |
Scios Inc. |
Method, composition and device for sampling natriuretic peptides in a biological fluid
|
|
SI2827152T1
(en)
|
2008-04-18 |
2016-10-28 |
Critical Care Diagnostics,Inc. |
Predicting risk of major adverse cardiac events
|
|
US8778699B2
(en)
|
2010-08-04 |
2014-07-15 |
Idexx Laboratories, Inc. |
Detection of degradation products of canine NT-proBNP
|
|
ES2897419T3
(en)
|
2011-03-17 |
2022-03-01 |
Critical Care Diagnostics Inc |
Procedures for predicting the risk of an adverse clinical outcome
|
|
CA2856798A1
(en)
|
2011-05-31 |
2012-12-06 |
Idexx Laboratories, Inc. |
Detection of degradation products of feline nt-probnp
|
|
CN102854321B
(en)
*
|
2012-07-26 |
2015-09-02 |
博奥赛斯（天津）生物科技有限公司 |
N end Type B plasma pro-brain natriuretic peptide levels chemiluminescence immunoassay immue quantitative detection reagent box and preparation method thereof
|
|
SG10201608854TA
(en)
|
2012-08-21 |
2016-12-29 |
Critical Care Diagnostics Inc |
Multimarker risk stratification
|
|
CN107478848B
(en)
*
|
2017-08-23 |
2019-04-16 |
广州瑞博奥生物科技有限公司 |
The kit and preparation method thereof of quantitative detection people NT-proBNP
|